ArticleOxidative medicine and cellular longevity2014

The higher plasma malondialdehyde concentrations are determined by metabolic syndrome-related glucolipotoxicity.

Fernando Moreto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.